First-to-market D2C B2B nutraceutical ingredient and supplement company seeks investment for expansion.

Gold-standard research has established our product as an elite, unique breakthrough branded ingredient and finished goods that have been commercially tested and proven in the Australasian, US and UK marketplace.
As a supplier to English Premier League football clubs, and high-performance sports organizations such as the US Military, our product is used in the services and elite sports to provide a proven, legal competitive advantage. We have an official New Zealand All Blacks, product and collaborate with sports supplement companies such as Healthspan Elite and Science in Sport.
Aside from finished goods, we have the branded ingredient, backed by a volume of clinicals, making a high-growth potential product in the US and EU.
With restrictions on health claims in the EU, our finished goods marketing strategy is focused on the US, where we entered the market in 2022 and seeing strong growth in our D2C channels.
Our unique provenance story centers around NZ’s powerful climate, which produces an exceptional polyphenol-rich berry fruit unique to the region. With concentrations and combinations of bioactive not present in any other berry, our fruit is key to producing a high-quality, high-potency extract that delivers a host of antioxidant, vasodilatory, and anti-inflammatory actions.
The product’s exceptional multiplicity of physiological properties has led to international brand recognition, with five Sports Nutrition Product Champion awards (Nutra Ingredients/ESSNA - Europe, USA, Asia), and three Best Recovery Product titles (UK, Europe). We have been shortlisted once again for the Champion Sports Nutrition Award in Europe this year.
With our product name-checked in all published studies, our material and science are responsible for many of the major anthocyanin-derived breakthroughs of the last decade.
Our current combined revenues are operating at approx USD 700,000 from our small business enterprises in the UK, NZ, and Australia.
As the first-to-market New Zealand blackcurrant brand, the company’s primary focus is to capitalize on a decade of research investment and development. A well-supported sales and marketing strategy can leverage this rare offering with the right strategic partner.

Our flagship product is an international award-winning breakthrough in sports and cardiometabolic health nutrition. Made from a proprietary, high-potency anthocyanin extract, our product is used by athletes, competitive, recreational and grassroots users and older adults looking to improve their cardiovascular and metabolic health outcomes.

We have two majority shareholders owning 79.86% and the balance split between 18 shareholders, following a small cap raise 6 years ago. The business has two commercial loans, a shareholder loan and uses Shopify Working Capital.

63 human clinical trials (value USD$3-4m) Stock (4-product range) Brand assets, three websites, international trademarks, 12-year commercial track record. Basic tools and office supplies.